{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Maria Faelth Savitski"}, {"accession": "MS:1000589", "name": "contact email", "value": "maria.x.faelth-savitski@gsk.com"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Cellzome"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Marcus Bantscheff"}, {"accession": "MS:1000589", "name": "contact email", "value": "marcus.x.bantscheff@gsk.com"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Cellzome"}]}], "datasetFiles": [{"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007638/F228283.dat"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007638/F228289.dat"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007638/04776_F1_R1_P0103248A01_TMT10.raw.gz"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007638/04776_F1_R1_P0103252A01_TMT10.raw.gz"}], "description": "The goal of this experiment was the confirmation of ZAK as a covalent target of Ibrutinib by an affinity enrichment experiment with a linkable analogue of Ibrutinib.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007638"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD007638"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD007638"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Ibrutinib, Ramos B-lymphocyte lysate, lysate-based assay, linkable Ibrutinib affinity enrichment, SDS elution vs bead trypsinationLC-MS/MS"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}], "modifications": [{"accession": "MOD:01720", "name": "TMT6plex-126 reporter+balance reagent acylated residue"}, {"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00394", "name": "acetylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "28876896"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Dittus L, Werner T, Muelbaier M, Bantscheff M. Differential Kinobeads Profiling for Target Identification of Irreversible Kinase Inhibitors. ACS Chem Biol. 2017"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Confirmation of ZAK as covalent target of Ibrutinib"}